Skip to main content
Clinical Trials/EUCTR2008-005859-16-DE
EUCTR2008-005859-16-DE
Active, not recruiting
Not Applicable

Prospective randomized Multicenter study in first-line treatmentof Advanced progredIeNT follicular And other IndoleNt and mantle cell lymphomas - MAINTAI

StiL Forschungs-GmbH0 sites874 target enrollmentNovember 20, 2008

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Indolent Non-Hodgkin Lymphomas, in particular follicular lymphomas, as well as marginal zone lymphomas, immunocytomas (Waldenström’s macroglobulinaemia) and mantle cell lymphomas
Sponsor
StiL Forschungs-GmbH
Enrollment
874
Status
Active, not recruiting
Last Updated
13 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 20, 2008
End Date
TBD
Last Updated
13 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
StiL Forschungs-GmbH

Eligibility Criteria

Inclusion Criteria

  • Patients with histological verified CD20\-positive B\-cell\-lymphoma of the following entities:
  • follicular lymphoma
  • immunocytoma / Waldenström’s macroglobulinaemia and small\-cell lymphocytic lymphoma without leukaemic phase of the disease
  • marginal zone lymphoma
  • mantle cell lymphoma
  • no pretreatment with cytostatics, interferon or monoclonal antibodies
  • in need for therapy, except mantle cell lymphoma
  • stages III or IV or stage II bulky disease
  • performance status (WHO) 0\-2
  • minimum age 18 years maximum age 80 years

Exclusion Criteria

  • Patients not meeting the criteria of E 3
  • Potential curative radiotherapy as alternative option
  • Pre\-treatment except singular locally confined radiotherapy (radiation field not larger than two adjacent lymph node regions)
  • concomitant disease which impedes the study equitable therapy like: severe, medicinal uncontrollable hypertension, severe disorder of the heart or lung or liver or kidney, except if caused by the lymphoma
  • patients with proven HIV\-infection
  • active and replicating hepatitis\-infection
  • severe psychiatric disorder
  • missing or anticipation of missing compliance
  • Pregnant or breastfeeding women
  • Patients with a second malignoma or malignant disease in their history, if surgery is anticipated not to be curable.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Phase 4
Multicenter Prospective Randomized Study of First-choice Guidewires in Percutaneous Coronary Intervention for Chronic Total OcclusioPatients undergoing Percutaneous Coronary Intervention (PCI) for chronic total occlusion (CTO)
JPRN-UMIN000002573Tokai University290
Active, not recruiting
Not Applicable
Prospective randomized multicenter study to prevent chemotherapy induced ovarian failure with the GnRH-Agonist Goserelin in young hormone insensitive breast cancer patients receiving anthracycline containing (neo-)adjuvant chemotherapy (GBG 37) - Zoro-young hormone insensitive breast cancer patients receiving anthracycline containing (neo-)adjuvant chemotherapy
EUCTR2004-003980-62-DEGBG Forschungs GmbH62
Completed
Phase 4
*A prospective randomized multicenter study to demonstrate the superiority of the Barricaid® to discectomy for primary lumbar disc herniation*: Extended Follow-Up of the Barricaid® Annular Closure Device (ACD) Randomized Control Trial (RCT) Postmarket Cohort for Lumbar Disc Herniation and Interaction with Other Risk Factorslumbar disc herniationsciatica100432371004154310009720
NL-OMON55882Intrinsic Therapeutics, GmbH66
Not yet recruiting
Phase 4
To compare effectiveness, safety and tolerability of Lulican shampoo versus ketoconazole shampoo, in patients having scalp dermatitis.Health Condition 1: L210- Seborrhea capitis
CTRI/2021/09/036865Anisha Clinic
Recruiting
Not Applicable
Multicenter and Prospective Clinical Study for the Development of Multi-Omics-Based Biomarkers in Acute Myeloid LeukemiaDiseases of the blood and blood -forming organs and certain disorders involving the immune mechanism
KCT0004825Chonnam National University Hospital Hwasun Hospital620